Alkermes Pharmaceutical Logo Vector
Alkermes' flagship product, Lybrido (brexpiprazole), is an injectable atypical antipsychotic medication used to treat schizophrenia and bipolar disorder. Lybrido is known for its efficacy, safety, and tolerability. Alkermes is also developing a pipeline of promising new therapies for other CNS disorders, including Alzheimer's disease, pain, and addiction.